Medical device company Biovo Technologies Ltd revealed on Thursday that it has commissioned its Cuffix devices in the largest newly established COVID-19 ward in one of Israel's leading hospitals, with a capacity of 170 ventilated patients.
The company added that Cuffix is the first and only economical, self-contained, disposable cuff pressure regulator and monitor in the market.
As ICUs are full and medical personnel is stretched to the limit, the single use products including Cuffix can assist with treating COVID-19 patients and reduce nurse work load. This has dramatically increased worldwide interest in Biovo's products.
Under the company's plan to increase sales and production volumes, it has signed distribution agreements in Australia and Brazil and following the recent 510K FDA clearance, the next commercialization step is in the USA and discussions are already underway.
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial
Implantica's RefluxStop receives US FDA approval
Sectra to provide Education Portal to Loyalist College for medical imaging training
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
Abbott and NACHC launch nationwide Food for Health initiative
Galmed reports positive preclinical results for Aramchol in prostate cancer
Galderma receives EU approval for Restylane Shaype facial shaping injectable